Login / Signup
Vishal Bhatnagar
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 7
Top Topics
Clinical Trial
Bipolar Disorder
High Grade
Phase Ii
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jaleh Fallah
,
Brian L Heiss
,
Hee-Koung Joeng
,
Chana Weinstock
,
Xin Gao
,
William F Pierce
,
Benjamin Chukwurah
,
Vishal Bhatnagar
,
Mallorie H Fiero
,
Laleh Amiri-Kordestani
,
Richard Pazdur
,
Paul G Kluetz
,
Daniel L Suzman
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Jason R Fangusaro
,
Robert A Avery
,
Michael J Fisher
,
Roger J Packer
,
Karin S Walsh
,
Antoinette Y N Schouten-van Meeteren
,
Dominik Karres
,
Diana Bradford
,
Vishal Bhatnagar
,
Harpreet Singh
,
Paul G Kluetz
,
Martha Donoghue
,
Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (11) (2024)
Jason R Fangusaro
,
Robert A Avery
,
Michael J Fisher
,
Roger J Packer
,
Karin S Walsh
,
Antoinette Y N Schouten-van Meeteren
,
Dominik Karres
,
Diana Bradford
,
Vishal Bhatnagar
,
Harpreet Singh
,
Paul G Kluetz
,
Martha Donoghue
,
Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Jason R Fangusaro
,
Robert A Avery
,
Michael J Fisher
,
Roger J Packer
,
Karin S Walsh
,
Antoinette Y N Schouten-van Meeteren
,
Dominik Karres
,
Diana Bradford
,
Vishal Bhatnagar
,
Harpreet Singh
,
Paul G Kluetz
,
Martha Donoghue
,
Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (11) (2024)
Jason R Fangusaro
,
Robert A Avery
,
Michael J Fisher
,
Roger J Packer
,
Karin S Walsh
,
Antoinette Y N Schouten-van Meeteren
,
Dominik Karres
,
Diana Bradford
,
Vishal Bhatnagar
,
Harpreet Singh
,
Paul G Kluetz
,
Martha Donoghue
,
Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Jason R Fangusaro
,
Robert A Avery
,
Michael J Fisher
,
Roger J Packer
,
Karin S Walsh
,
Antoinette Y N Schouten-van Meeteren
,
Dominik Karres
,
Diana Bradford
,
Vishal Bhatnagar
,
Harpreet Singh
,
Paul G Kluetz
,
Martha Donoghue
,
Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (11) (2024)
Jason R Fangusaro
,
Robert A Avery
,
Michael J Fisher
,
Roger J Packer
,
Karin S Walsh
,
Antoinette Y N Schouten-van Meeteren
,
Dominik Karres
,
Diana Bradford
,
Vishal Bhatnagar
,
Harpreet Singh
,
Paul G Kluetz
,
Martha Donoghue
,
Elizabeth S Duke
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (11) (2024)